|
|
||||||||
J Thorac Cardiovasc Surg 2000;119:508-514
© 2000 Mosby, Inc.
SURGERY FOR CONGENITAL HEART DISEASE |
From the Department of Cardiac Surgery, Childrens Hospital, Boston, Mass.
Address for reprints: Richard A. Jonas, MD, Department of Cardiac Surgery, Childrens Hospital, 300 Longwood Ave, Boston, MA 02115.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Primary repair of truncus arteriosus during the neonatal period and infancy has become the established practice.
3,4 The excellent results of surgical repair of truncus arteriosus reported in most centers have not applied to those patients with significant truncal valve regurgitation and associated interrupted arch. Truncal valve dysfunction is estimated to occur in up to 25% of patients with truncus arteriosus.
5 This figure may be an underestimation of truncal valve dysfunction because of the large runoff of blood to the pulmonary circulation. In some series, valve regurgitation was identified by poor hemodynamic performance when the patient was weaned from cardiopulmonary bypass (CPB). The surgical options for truncal valve regurgitation have been homograft replacement with coronary reimplantation, mechanical valve replacement, and valve repair. The first two options condemn the patient to multiple further operations with risks of eventual valve failure, anticoagulation, and prosthetic valve endocarditis. The recently reported disappointing results of homograft valve replacement
6,7 make truncal valve repair a more attractive option. In an earlier series from Childrens Hospital, Boston, truncal valve regurgitation and interrupted aortic arch were identified as risk factors for perioperative death.
3
The purpose of this study was to examine the treatment of patients with truncal valve regurgitation and interrupted aortic arch in the current era and to compare the outcome in these cases with that in the less complex forms of truncus arteriosus.
| Patients and methods |
|---|
|
|
|---|
|
|
The principle of valve repair was improved leaflet apposition. This was achieved by approximation of the incomplete commissures and resuspension of the true commissures. The rudimentary commissures were closed with 7-0 Prolene polypropylene sutures supported with pericardial pledgets. If there was some redundancy in the anulus, this was reduced by taking a tuck at the attachment of the raphe of the commissure and the aortic wall. Reduction of the sinuses of Valsalva was done when indicated. Three patients had quadricusp valves, in which 2 cusps were relatively normal and the other 2 cusps were partially fused at a rudimentary commissure. One patient had 5 leaflets with 3 large leaflets and 2 additional leaflets. The fifth patient had a bicuspid valve. A 5-day-old neonate weighing 2.9 kg with severe truncal valve regurgitation underwent homograft root replacement (aortic homograft, 11 mm) with coronary reimplantation. This patient was operated on early in the series.
Patients with interrupted aortic arch
Associated interrupted aortic arch was repaired in 9 patients. Eight patients had type B and 1 patient had type A interrupted arch. The median age was 17 days (range, 4 days6 months). Seven patients were younger than 1 month old, 1 was 6 weeks old, and another was 6 months old. None of the patients with associated interrupted aortic arch had truncal valve regurgitation.
After wide mobilization of the ascending and descending aorta and control of the arch vessels, direct anastomosis was achieved in 5 patients. In the other 4 patients partial direct anastomosis was augmented with a pericardial or homograft gusset.
Statistical analysis
Median age, weight, and time to reoperation were compared by the Mann-Whitney U test. Differences in CPB, crossclamp, and circulatory arrest times were evaluated by the unpaired Student t test. The analysis of reoperation was done with the Cox proportional hazard model,
8 using the following variables: age, weight at operation, sex, presence of truncal valve regurgitation, interrupted aortic arch, CPB time, and crossclamp time. Percent survival at 30 days, 1 year, and 3 years and freedom from reoperation were determined by the Kaplan-Meier product-limit method and a 95% confidence interval estimated by the Greenwood formula.
9 Two-tailed values of probability (P ) were determined. Data analysis was done with the SPSS software package (version 8.0, SPSS Inc, Chicago, Ill).
| Results |
|---|
|
|
|---|
The second death was in a 2-week-old boy weighing 3.5 kg. This patient had mild to moderate truncal valve regurgitation and dual origin of the left anterior descending coronary artery. After repair, the patient was weaned from CPB with moderate support. He had complete heart block and pacing was required. One hour after arrival in the intensive care unit he had a cardiac arrest and after resuscitation was placed on extracorporeal membrane oxygenation (ECMO) support. There was no suggestion of tamponade or pulmonary hypertensive crisis accounting for the arrest. The next 48 hours were complicated by severe coagulopathy and bleeding. Transesophageal echocardiography revealed poor left ventricular function and a thrombosed conduit. The patient was returned to the operating room for replacement of the conduit and subsequently was maintained on ECMO support for a further 48 hours. His course was complicated by Aspergillus mediastinitis. It was also demonstrated that the excised homograft was infected with Aspergillus. All attempts at weaning from ECMO were unsuccessful and at this point the patient had overwhelming sepsis. Resuscitation was ceased.
Patients with truncal valve regurgitation
There were 2 deaths in the group of patients with truncal valve regurgitation. Both cases were discussed in the preceding section. Of the 5 patients who underwent truncal valve repair, none died. Two patients had transesophageal echocardiography done in the operating room after weaning from CPB that showed minimal valvular regurgitation. Transthoracic echocardiography done after the operation in all patients having repair showed mild valvular regurgitation in 2 patients and 3 patients had no truncal valve regurgitation.
Transthoracic echocardiography at the most recent follow-up showed minimal valvular regurgitation in the 5 patients who underwent repair. Of the 8 patients who did not undergo truncal valve repair or replacement, 5 with mild truncal valve regurgitation and 2 with moderate truncal valve regurgitation did not have any deterioration of valve function at follow-up. One patient with moderate valvular regurgitation has had some deterioration in valve function.
Patients with associated interrupted aortic arch
There were no deaths in the group of patients with associated interrupted aortic arch, and the median hospital stay was not significantly different from the stay in those patients without interrupted aortic arch. Obstruction across the arch anastomosis was defined as a pressure gradient of 30 mm Hg or greater defined by transthoracic echocardiography. At follow-up, none of the patients had any degree of arch obstruction.
Freedom from reoperation
Conduit replacement has been done in 17 patients (34%) with a median interval of 3 years. The median aortic homograft size at the initial operation was 10 mm and the median pulmonary homograft size was also 10 mm. The median time for reoperation for patients who had an aortic homograft was 4 years (range, 8 months7 years) and for those who had a pulmonary homograft, 3 years (range, 11 months4 years). This difference was not significant (P = .87). By the Cox proportional hazard model, patients with a larger homograft size had a longer period of freedom from conduit replacement. None of the patients has required reoperation because of truncal valve problems or aortic arch stenosis. The actuarial survival was 96% at 30 days, 1 year, and 3 years (Fig 1). Freedom from reoperation is shown in Fig 2.
|
|
| Discussion |
|---|
|
|
|---|
The disappointing results of truncal valve replacement and the success of aortic valve repair in the adult population have increased interest in the repair of truncal valve insufficiency.
10-12 In this study, 5 patients underwent truncal valve repair. In all 5 patients, truncal valve insufficiency was diagnosed preoperatively and therefore valve repair was a planned procedure. In the most recent previous series from Childrens Hospital, Boston, 4 of 8 patients with truncal valve insufficiency died. On further analysis of the 4 deaths, only 1 patient had replacement as a planned part of the primary repair. In another, valve replacement was done after failure to wean from CPB. Two patients died in the perioperative period before valve replacement could be accomplished. Of the 4 patients who survived, 2 underwent perioperative valve replacement and 2 underwent replacement at 6 and 12 months, respectively. In the current series, none of the patients who underwent truncal valve repair has required intervention at a median follow-up of 14 months (range, 3-36 months).
It is thought that nodular or dysmorphic valves are more likely to be insufficient and have an abnormal number of leaflets
2 and that quadricusp valves are more regurgitant than tricuspid valves.
13 In this study, the number of patients who underwent truncal valve repair is too small to extrapolate as to which type of valve would best be served by valvuloplasty techniques. Most probably, conversion of a quadricusp valve to a tricuspid valve will be most productive, because it will restore a trileaflet morphology. It may be that repair resulting in bicuspid morphology would predispose to future valve stenosis.
The results of truncal valve replacement have been disappointing. In the current series, the 1 patient who underwent truncal valve replacement because of valve regurgitation died in the postoperative period. Elkins and colleagues
7 have reported the cases of 4 patients who underwent homograft replacement of the truncal valve, 2 of whom died in the early postoperative period. In a report by McElhinney and colleagues,
14 3 of the 4 neonates who received allograft root replacement died within 7 months after repair and the fourth required replacement after 1 year because of severe homograft insufficiency. Four of their 6 patients who required mechanical valve replacement died in the early postoperative period. The risks of mechanical valve replacement in the small truncal root, impairing normal growth of the native anulus as well as subjecting the child to long-term anticoagulation, should be weighed against potential benefits.
The results in this series with associated interrupted arch have improved significantly compared with results in the previous report,
3 in which 3 of 6 patients died after repair. There were no deaths in the 9 patients who underwent complete repair. Of the 9 patients who underwent repair, 7 were younger than 1 month old.
We advocate direct anastomosis between the ascending and the descending aorta. A gusset of homograft can be used for augmentation of the anastomosis if there is important size disparity. Others have suggested the use of subclavian artery in type A interrupted aortic arch and the use of both the subclavian and the left carotid arteries in type B interrupted aortic arch.
15 In this method, the arch vessels are divided distally and then filleted open to form the superior part of the neo-aortic arch. Those authors believe that the risk of stenosis is reduced. However, this has to be balanced against the risk of cerebral damage.
16 At a mean follow-up of 13 months (range, 1-48 months), none of the patients in our series has been seen because of restenosis. Although the follow-up is too short in this group to draw any inferences regarding the method of repair, it is unlikely that circumferential anastomosis per se will result in stenosis, as has been shown in infants and neonates who have undergone the arterial switch operation.
17
In conclusion, despite the magnitude of this operation, excellent results can be achieved in complex forms of truncus arteriosus. We advocate complete one-stage repair in these patients. In patients with truncal valve regurgitation, valve repair is a preferable option to valve replacement. In the current era, associated interrupted aortic arch may no longer be associated with increased mortality in patients undergoing repair of truncus arteriosus.
| Appendix: Discussion |
|---|
|
|
|---|
Not long ago many authors, including those from the current report, found that repair of truncus arteriosus was associated with a higher mortality when there was coexisting arch interruption or truncal valve regurgitation. Why are the results better now? Although the answers are not always readily apparent from a retrospective data review, it seems clear that a number of factors, including earlier age at operation, better preoperative and postoperative management, and increased experience with the repair of arch abnormalities of all kinds in neonates, have played significant roles.
Importantly, however, the results presented today also indicate that truncal valve repair is a particularly useful option in the management of significant truncal valve regurgitation. This knowledge will allow surgeons to avoid the delay in operation that has so often been used when the truncal valve must be dealt with and also to avoid the technical complexity introduced by truncal valve replacement itself, thus removing arguably the two most significant risk factors associated with the need for truncal valve replacement.
A few years ago, our group reported excellent survival with severe truncal valve regurgitation when truncal valve replacement was undertaken without delay, even in neonates, indicating that delaying the operation plays an important role in the outcome, as also demonstrated for uncomplicated truncus, and that operating on a patient with worsening left ventricular dysfunction and in poor preoperative condition was itself associated with a higher risk. Thus prompt truncal valve replacement can be done satisfactorily. However, the problems associated with the need for repeated replacement of the truncal valve in growing babies present yet another set of risks that can and should be avoided by early valve repair as demonstrated by the authors. However, although it appears that repair is possible even in severely malformed valves, the limitations of this technique are not fully understood.
Similarly outstanding results can now be expected with associated interruption of the arch, a condition that has not posed an increased risk in our institution for a considerable time. The authors prefer a primary anastomosis, a technique with which we would agree, although arch augmentation with a homograft patch is another useful tool that allows for a better size match between the distal aorta and the often small segment of ascending aorta that is left after removal of the duct and the pulmonary arteries. We have increasingly used the Lecompte maneuver to translocate the branch pulmonary arteries anteriorly to facilitate conduit placement.
I have three main questions for Dr Jonas. First, you used repair of the truncal valve in 5 of the 9 patients in your series who had at least moderate regurgitation. Although no doubt your indications were evolving over time, could you tell us why the other 4 patients were not treated in a similar fashion and what their postoperative outcomes and echocardiograms showed? Do you now recommend repair for any patient with at least moderate regurgitation?
Second, have you identified any morphologic characteristics of the truncal valve that may be predictive of successful repair? In particular, what about those valves that are very immobile, often with significant degrees of stenosis? It has certainly been our experience that patients with severe truncal valve regurgitation also have gradients across the valve, admittedly because of the large volume flow, but often also because of the very thickened and immobile leaflets.
Finally, have you seen any bronchial obstruction after your technique of repair of the interrupted aortic arch?
Dr Jonas. The reason that all patients with at least moderate regurgitation did not have repair is that this has been a combined experience of several surgeons. I have been enthusiastic about truncal valve repair for some time, but I believe now all of us in Boston are catching on to this idea.
I think your second point is one of the important reasons we have started to become more enthusiastic, and that is because of an appreciation that gradients detected across these valves preoperatively are usually eliminated by eliminating the regurgitation. The same has been true with aortic valve repairs as well in that much of the supposed stenosis is in fact an artifact and simply a reflection of the huge volume load that these valves are carrying before operation. Remember that not only are truncal valves carrying the regurgitant fraction but they are also carrying the entire pulmonary blood flow. I personally have yet to see a valve that has had fixed immobile leaflets that would not be suitable for repair. Perhaps they do exist and perhaps one would not be able to repair them, but I think they are rare.
As to the status of the patients with moderate regurgitation who did not receive repair, I would like to call on Dr Jahangiri to comment. As far as I am aware, none has required a subsequent valve operation, so I believe that they have remained in stable condition. However, certainly our threshold for repairing valves is constantly coming down and that applies to both aortic valves and truncal valves.
Regarding bronchial obstruction, I think we learned a long time ago with simple interrupted aortic arch that very wide mobilization of the descending aorta and the arch vessels is important, and that one has to bring the head vessels down as well as bring the descending aorta up to the anastomosis. This helps reduce the tension on the anastomosis, which fundamentally is the cause of left bronchial obstruction.
I believe also the concept of dividing the truncus rather than taking the pulmonary arteries off the side is important. Often a major bulge out of the left side of the truncus will result if you simply take the pulmonary arteries off. Especially if you have essentially type I truncus and simply take the pulmonary arteries off, leaving the ascending aorta in continuity, then the routing of the conduit becomes complex and can result in compression of the conduit, compression of the coronary arteries, and so on. I think by shifting the whole trunk rightward by doing a complete division, and also tailoring the rest down to improve the valve, one avoids obstructive problems all around.
Dr V. Mohan Reddy (San Francisco, Calif). Dr Jahangiri and Dr Jonas and their group have shown excellent results. I definitely agree with their conclusion. Our experience says that truncal valve repair is the preferred treatment in these patients. In our early experience, we tended to use allograft replacement. Certainly all the patients survived, but within a few months severe allograft regurgitation developed, and we subsequently gave up using allografts in favor of repair. I would like to ask Dr Jonas what happened to the one patient in whom you had replaced the truncal valve with an allograft?
Dr Jonas. Dr Jahangiri, can you clarify that for us? I do not recall reoperating on that patient, but certainly we have seen accelerated calcification when we have used homografts. Did that patient require reoperation?
Dr Jahangiri. That patient was one of those who died in the series. We had to leave the chest open because the heart was swollen with increasing edema. The patient was sent to the intensive care unit and required considerable inotropic support. Subsequently, in the next 48 hours, candidiasis developed and the patient died of uncontrolled sepsis.
Dr Reddy. I would like to add a cautionary note. When allografts were placed in neonates with associated very severe regurgitation, allograft regurgitation developed within 3 months. We did this procedure in 4 patients early in our experience and all of them required replacement within the first 6 months.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
P. K. Mishra Management strategies for interrupted aortic arch with associated anomalies Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 569 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lacour-Gayet and S. Goldberg Surgical repair of truncus arteriosus associated with interrupted aortic arch MMCTS, March 28, 2008; 2008(0328): 2451. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. I. Schmidt, M. Jeserich, D. Aicher, and H.-J. Schafers Tricuspidization of the Quadricuspid Aortic Valve Ann. Thorac. Surg., March 1, 2008; 85(3): 1087 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Henaine, K. Azarnoush, E. Belli, A. Capderou, R. Roussin, C. Planche, and A. Serraf Fate of the Truncal Valve in Truncus Arteriosus Ann. Thorac. Surg., January 1, 2008; 85(1): 172 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kalavrouziotis, M. Purohit, G. Ciotti, A. F. Corno, and M. Pozzi Truncus Arteriosus Communis: Early and Midterm Results of Early Primary Repair Ann. Thorac. Surg., December 1, 2006; 82(6): 2200 - 2206. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Chen, P. Modi, M. Caputo, and A. Pawade Truncus Arteriosus With Interrupted Aortic Arch: Successful Repair Using Modified Cardiopulmonary Bypass and Surgical Techniques Ann. Thorac. Surg., November 1, 2006; 82(5): 1884 - 1886. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Laudito, E. M. Graham, M. R. Stroud, V. Bandisode, A. N. Bhat, F. A. Crawford Jr, A. M. Atz, and S. M. Bradley Complete repair of conotruncal defects with an interatrial communication: oxygenation, hemodynamic status, and early outcome. Ann. Thorac. Surg., October 1, 2006; 82(4): 1286 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Akintuerk, G. Goerlach, K. Valeske, M. Mueller, J. Bauer, S. Scholz, and D. Schranz Transplantation in truncus arteriosus combined with interrupted aortic arch. Ann. Thorac. Surg., October 1, 2006; 82(4): 1535 - 1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. E. Konstantinov, T. Karamlou, E. H. Blackstone, R. S. Mosca, G. K. Lofland, C. A. Caldarone, W. G. Williams, A. S. Mackie, and B. W. McCrindle Truncus Arteriosus Associated with Interrupted Aortic Arch in 50 Neonates: A Congenital Heart Surgeons Society Study Ann. Thorac. Surg., January 1, 2006; 81(1): 214 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Lacour-Gayet Invited commentary Ann. Thorac. Surg., January 1, 2006; 81(1): 222 - 223. [Full Text] [PDF] |
||||
![]() |
T. Tlaskal, B. Hucin, V. Kucera, P. Vojtovic, R. Gebauer, V. Chaloupecky, and J. Skovranek Repair of persistent truncus arteriosus with interrupted aortic arch Eur. J. Cardiothorac. Surg., November 1, 2005; 28(5): 736 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miyamoto, N. Sinzobahamvya, D. Kumpikaite, B. Asfour, J. Photiadis, A. M. Brecher, and A. E. Urban Repair of Truncus Arteriosus and Aortic Arch Interruption: Outcome Analysis Ann. Thorac. Surg., June 1, 2005; 79(6): 2077 - 2082. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Oosterhof, A. Azakie, R. M. Freedom, W. G. Williams, and B. W. McCrindle Associated Factors and Trends in Outcomes of Interrupted Aortic Arch Ann. Thorac. Surg., November 1, 2004; 78(5): 1696 - 1702. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Thompson, D. B. McElhinney, V. M. Reddy, E. Petrossian, N. H. Silverman, and F. L. Hanley Neonatal repair of truncus arteriosus: continuing improvement in outcomes Ann. Thorac. Surg., August 1, 2001; 72(2): 391 - 395. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mavroudis and C. L. Backer Surgical management of severe truncal insufficiency: experience with truncal valve remodeling techniques Ann. Thorac. Surg., August 1, 2001; 72(2): 396 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Suominen, R. Palo, H. Sairanen, K.T. Olkkola, and J. Rasanen Perioperative determinants and outcome of cardiopulmonary arrest in children after heart surgery Eur. J. Cardiothorac. Surg., February 1, 2001; 19(2): 127 - 134. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |